Errors in the OR

Article

Poor communication is leading to a high number of mistakes in ophthalmic surgeries, according to a study published in the November issue of Archives of Surgery.

Poor communication is leading to a high number of mistakes in ophthalmic surgeries, according to a study published in the November issue of Archives of Surgery.

The study of surgery-related adverse events at Veterans Health Administration Medical Centres in the US looked at 342 reported events, including 212 adverse events, where a surgical procedure was performed unnecessarily. Of these adverse events, 45 were associated with ophthalmology, joint highest along with invasive radiology. The researchers calculated that 1.8 in every 10,000 cases feature an adverse event, commonly a lens mix up, which occurred in 48.9% of these events.

Communication was identified as the leading cause of these events, taking the blame in 21%. The authors suggest that earlier communication based on crew resource management would be beneficial in preventing some of these events.

The researchers acknowledged that not all mistakes are reported and that the frequency of reported events in ophthalmology could reflect a quality assurance-attentive department head. The authors suggest that a standardized system would allow for more reliable data capturing in this area.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.